Cayuga Biotech Press Releases - EIN Presswire - Press Release Distribution Service

Published on December 15, 2025 - 15:30 GMT

First Subject Dosed in Phase 1 Clinical Trial for CAY001 for Life-Threatening Hemorrhage

NEW YORK, NY, UNITED STATES, December 15, 2025 /⁨EINPresswire.com⁩/ -- Cayuga Biotech, Inc., a clinical-stage company developing novel therapeutics to address hemorrhage, today announced that the first subject has been dosed in its Phase 1 clinical trial …

Distribution channels: Banking, Finance & Investment Industry, Emergency Services ...

Published on December 11, 2025 - 15:25 GMT

Cayuga Closes $8M Seed Funding

Novel Therapeutic for Life-Threatening Hemorrhage, CAY001, to Advance to Clinic NEW YORK, NY, UNITED STATES, December 11, 2025 /⁨EINPresswire.com⁩/ -- Cayuga Biotech, Inc., a company developing novel therapeutics to address life-threatening hemorrhage, …

Distribution channels: Banking, Finance & Investment Industry, Emergency Services ...

Published on November 5, 2025 - 15:00 GMT

Full Data on Cayuga’s Novel Synthetic Compound in Stopping Life-Threatening Hemorrhage Shows Promise

PolyP-SNP Complex Has Potential to Restore Blood Clotting Under Most Dangerous Conditions of Traumatic Injury NEW YORK, NY, UNITED STATES, November 5, 2025 /⁨EINPresswire.com⁩/ -- Cayuga Biotech, Inc., a company developing novel therapeutics to address …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on March 29, 2025 - 20:30 GMT

Cayuga's CAY001 Significantly Increases Survival and Improves Bleeding Outcomes in Platelet Inhibitor-Related Bleeding

Data on CAY001, a First-in-Class, Polyphosphate (polyP)-Based Therapy, Show Promise in Bypassing P2Y12 Inhibition to Restore Normal Clotting Function NEW YORK, NY, UNITED STATES, March 29, 2025 /⁨EINPresswire.com⁩/ -- Cayuga Biotech, a company that …

Distribution channels: Healthcare & Pharmaceuticals Industry, Military Industry ...

Published on December 10, 2024 - 02:00 GMT

Cayuga's poly-P-SNP Complex Demonstrates >90% Shorter Bleeding Time and Nearly 60% Less Blood Loss After Severe Injury

-- Data on Novel Synthetic Short-Chain Polyphosphate (polyP) Complexed with Silica Nanoparticle (SNP) Presented at 66th ASH Annual Meeting -- NEW YORK, NY, UNITED STATES, December 9, 2024 /⁨EINPresswire.com⁩/ -- Cayuga Biotech, a company that develops …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...